Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
作者:Jianzhang Wu、Shoubiao Wu、Lingyi Shi、Shanshan Zhang、Jiye Ren、Song Yao、Di Yun、Lili Huang、Jiabing Wang、Wulan Li、Xiaoping Wu、Peihong Qiu、Guang Liang
DOI:10.1016/j.ejmech.2016.10.027
日期:2017.1
targeted for the therapy of various cancers, including lung cancer. EF24 was considered as a potent inhibitor of NF-κB signaling pathway. In this study, a series of asymmetric EF24 analogues were synthesized and evaluated for their anti-cancer activity against three lung cancer cell lines (A549, LLC, H1650). Most of the compounds exhibited good anti-tumor activity. Among them, compound 81 showed greater
核因子-κB(NF-κB)信号通路已被靶向用于治疗各种癌症,包括肺癌。EF24被认为是有效的NF-κB信号通路抑制剂。在这项研究中,合成了一系列不对称的EF24类似物,并评估了它们对三种肺癌细胞系(A549,LLC,H1650)的抗癌活性。大多数化合物表现出良好的抗肿瘤活性。其中,化合物81显示出比EF24更大的细胞毒性。化合物81还具有浓度依赖性的针对A549细胞的有效的抗迁移和抗增殖能力。此外,化合物81通过抑制NF-κB信号传导途径诱导肺癌细胞死亡,并通过增加活性氧(ROS)的产生来激活JNK-线粒体凋亡途径,从而导致细胞凋亡。